NNNN
Anbio Biotechnology
5.60$
-11.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41.3% | 57.2% | 33.1% | 15.4% | 7.7% | 18.5% | 18.5% | |
| 58.7% | 42.8% | 66.9% | 84.6% | 92.3% | 81.5% | 81.5% | |
| – | 3.7% | 2.2% | 14.0% | 2.9% | 1.7% | 1.7% | |
| 12.3% | 28.0% | 5.3% | 153.2% | 18.9% | 22.4% | 22.4% | |
| 46.5% | 14.8% | 61.5% | -68.6% | 73.4% | 59.1% | 59.1% | |
| 49.7% | 20.1% | 61.5% | -52.4% | 82.8% | 64.1% | 64.1% | |
| 49.7% | 20.1% | 61.5% | -52.4% | 82.8% | 64.1% | 64.1% | |
| 46.7% | 20.2% | 61.5% | -52.4% | 73.4% | – | 59.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.